A5068969389- Lymphoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- Cutaneous lymphoproliferative disorders research
- T-cell and Retrovirus Studies
- Chronic Myeloid Leukemia Treatments
- Monoclonal and Polyclonal Antibodies Research
- Polyomavirus and related diseases
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- CAR-T cell therapy research
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Lung Cancer Treatments and Mutations
- Renal Transplantation Outcomes and Treatments
- Viral-associated cancers and disorders
- Cancer therapeutics and mechanisms
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Hematological disorders and diagnostics
- Chemotherapy-induced cardiotoxicity and mitigation
- Animal Disease Management and Epidemiology
Montefiore Medical Center
2022-2025
Albert Einstein College of Medicine
2022-2025
The Bronx Defenders
2024
Montefiore Einstein Comprehensive Cancer Center
2024
Rutgers, The State University of New Jersey
2016-2022
Rutgers Cancer Institute of New Jersey
2004-2022
Johnson University
2016-2022
Yale Cancer Center
2006-2021
Yale University
2007-2017
Yale New Haven Hospital
2015-2016
Abstract The objective of our study was to report real-world data on the safety and efficacy standard-of-care teclistamab in patients with relapsed/refractory multiple myeloma (MM). This is a multi-institutional retrospective cohort included all consecutive that received at least one dose up until August 2023. One hundred ten were included, whom, 86% had triple-class refractory disease, 76% penta-refractory 35% prior exposure B-cell maturation antigen (BCMA)-targeting therapies. overall...
Tumor cell fusion with motile bone marrow-derived cells (BMDCs) has long been posited as a mechanism for cancer metastasis. While there is much support this from culture and animal studies, it yet to be confirmed in human cancer, tumor the same patient cannot easily distinguished genetically.We carried out genotyping of metastatic melanoma brain that arose following allogeneic bone-marrow transplantation (BMT), using forensic short tandem repeat (STR) length-polymorphisms distinguish donor...
Abstract Common variable immunodeficiency (CVID) is a primary disease characterized by low serum immunoglobulins IgG, IgA, and usually IgM. The central immune deficiency impaired secretion of lack antibody production; however, T cell dysfunction variety inflammatory complications suggest global dysregulation. A number reports have documented the association diseases with development non‐Hodgkin's lymphoma (NHL). In CVID, risk has been estimated to lie between 1.4% 7%. As for NHL arising in...
Background. Radiation therapy with or without surgery is generally considered standard treatment for lymphoma of the thyroid. Because small number cases, role chemotherapy combined modality difficult to determine. Methods. The published literature was analyzed, supplemented by a series from Yale, incidence local and distant relapse after radiation therapy, chemotherapy, Stage I-II thyroid lymphoma. Patients advanced disease in whom probably inadequate were excluded. Only patients...
The poor functional outcome in patients with advanced head and neck squamous cell carcinoma (HNSCC) surgery radiation has led to alternative approaches disease. We conducted a phase II study of induction chemotherapy followed by concurrent chemoradiotherapy for organ preservation resectable unresectable (nasopharyngeal) tumors.Forty-two stage III IV HNSCC nasopharyngeal tumors received two courses cisplatin (20 mg/m2/d continuous infusion [CI]), fluorouracil (800 CI), leucovorin (500 CI;...
PURPOSE Late solid tumors (STs) are a significant cause of morbidity and mortality in long-term survivors Hodgkin's disease. To investigate the carcinogenic potential two different therapeutic approaches, we measured relative risk (RR) STs patients with early-stage disease cured after primary full-dose (approximately 40 Gy) radiation therapy (RT) advanced who were treated chemotherapy followed by low-dose (15 to 30 involved-field (CMT). PATIENTS AND METHODS Because therapy-induced generally...
To determine the relationship between WHO and European Organization for Research Treatment of Cancer (EORTC) pathologic classifications primary cutaneous B-cell lymphoma (CBCL) implication this on initial treatment.Patients with CBCL treated radiotherapy were identified retrospectively. Initial biopsy specimens reviewed by two dermatopathologists classified according to EORTC systems. Primary outcomes recurrence-free overall survival.Thirty-four patients identified; adequate classification...
Not available.
ABSTRACT Background Clostridium difficile ( C. ) infection is a frequent complication following hematopoietic stem cell transplant, contributing to increased morbidity in this population. Despite current prevention strategies, rates among posttransplant patients at some centers remain high. Oral vancomycin safe and well‐tolerated antibiotic that may be potential adjunct prevent . Objectives To evaluate the effectiveness of oral preventing allogeneic transplant assess other outcomes. Study...